Review



high throughput next generation rna sequencing  (Novogene)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Novogene high throughput next generation rna sequencing
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    High Throughput Next Generation Rna Sequencing, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high throughput next generation rna sequencing/product/Novogene
    Average 86 stars, based on 1 article reviews
    high throughput next generation rna sequencing - by Bioz Stars, 2026-05
    86/100 stars

    Images

    1) Product Images from "Comparative RNA-Seq Analysis of Colon Spheroids and Patient-derived Tissues Identifies Non-Canonical Transcript Isoforms of Protein-Coding Genes Implicated in Colon Carcinogenesis"

    Article Title: Comparative RNA-Seq Analysis of Colon Spheroids and Patient-derived Tissues Identifies Non-Canonical Transcript Isoforms of Protein-Coding Genes Implicated in Colon Carcinogenesis

    Journal: Cancer Informatics

    doi: 10.1177/11769351251396250

    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk RNA-seq, and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    Figure Legend Snippet: (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk RNA-seq, and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.

    Techniques Used: Expressing, Standard Deviation, Derivative Assay, RNA Sequencing



    Similar Products

    high throughput next generation rna sequencing  (Novogene)
    86
    Novogene high throughput next generation rna sequencing
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    High Throughput Next Generation Rna Sequencing, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high throughput next generation rna sequencing/product/Novogene
    Average 86 stars, based on 1 article reviews
    high throughput next generation rna sequencing - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    high-throughput next-generation rna sequencing  (Novogene)
    90
    Novogene high-throughput next-generation rna sequencing
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    High Throughput Next Generation Rna Sequencing, supplied by Novogene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-throughput next-generation rna sequencing/product/Novogene
    Average 90 stars, based on 1 article reviews
    high-throughput next-generation rna sequencing - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    rna-sequencing (rna-seq) based on high-throughput next-generation sequencing (ngs)  (Illumina Inc)
    90
    Illumina Inc rna-sequencing (rna-seq) based on high-throughput next-generation sequencing (ngs)
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    Rna Sequencing (Rna Seq) Based On High Throughput Next Generation Sequencing (Ngs), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rna-sequencing (rna-seq) based on high-throughput next-generation sequencing (ngs)/product/Illumina Inc
    Average 90 stars, based on 1 article reviews
    rna-sequencing (rna-seq) based on high-throughput next-generation sequencing (ngs) - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    high throughput next generation rna sequencing  (Adaptive Biotechnologies Corp)
    90
    Adaptive Biotechnologies Corp high throughput next generation rna sequencing
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    High Throughput Next Generation Rna Sequencing, supplied by Adaptive Biotechnologies Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high throughput next generation rna sequencing/product/Adaptive Biotechnologies Corp
    Average 90 stars, based on 1 article reviews
    high throughput next generation rna sequencing - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    high-throughput next-generation rna sequencing  (Illumina Inc)
    90
    Illumina Inc high-throughput next-generation rna sequencing
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    High Throughput Next Generation Rna Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-throughput next-generation rna sequencing/product/Illumina Inc
    Average 90 stars, based on 1 article reviews
    high-throughput next-generation rna sequencing - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    next-generation high-throughput sequencing of the v3–v4 variable region of 16s ribosomal rna (rrna)  (SAS institute)
    90
    SAS institute next-generation high-throughput sequencing of the v3–v4 variable region of 16s ribosomal rna (rrna)
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    Next Generation High Throughput Sequencing Of The V3–V4 Variable Region Of 16s Ribosomal Rna (Rrna), supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/next-generation high-throughput sequencing of the v3–v4 variable region of 16s ribosomal rna (rrna)/product/SAS institute
    Average 90 stars, based on 1 article reviews
    next-generation high-throughput sequencing of the v3–v4 variable region of 16s ribosomal rna (rrna) - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    next-generation high-throughput sequencing platform illumina rna-seq  (Illumina Inc)
    90
    Illumina Inc next-generation high-throughput sequencing platform illumina rna-seq
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    Next Generation High Throughput Sequencing Platform Illumina Rna Seq, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/next-generation high-throughput sequencing platform illumina rna-seq/product/Illumina Inc
    Average 90 stars, based on 1 article reviews
    next-generation high-throughput sequencing platform illumina rna-seq - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    high-throughput rna sequencing based on next-generation sequencing  (Illumina Inc)
    90
    Illumina Inc high-throughput rna sequencing based on next-generation sequencing
    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk <t>RNA-seq,</t> and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.
    High Throughput Rna Sequencing Based On Next Generation Sequencing, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high-throughput rna sequencing based on next-generation sequencing/product/Illumina Inc
    Average 90 stars, based on 1 article reviews
    high-throughput rna sequencing based on next-generation sequencing - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    next-generation high-throughput sequencing v3–v4 variable region 16s ribosomal rna  (SAS institute)
    90
    SAS institute next-generation high-throughput sequencing v3–v4 variable region 16s ribosomal rna
    Summary characteristics of <t> 16S </t> <t> rRNA </t> sequence reads from fecal samples of rats fed 11% sugar solutions containing varying fructose-to-glucose ratios 1
    Next Generation High Throughput Sequencing V3–V4 Variable Region 16s Ribosomal Rna, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/next-generation high-throughput sequencing v3–v4 variable region 16s ribosomal rna/product/SAS institute
    Average 90 stars, based on 1 article reviews
    next-generation high-throughput sequencing v3–v4 variable region 16s ribosomal rna - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    small rnas (srnas) from the next generation high throughput solexa sequencing  (Solexa)
    90
    Solexa small rnas (srnas) from the next generation high throughput solexa sequencing
    Summary characteristics of <t> 16S </t> <t> rRNA </t> sequence reads from fecal samples of rats fed 11% sugar solutions containing varying fructose-to-glucose ratios 1
    Small Rnas (Srnas) From The Next Generation High Throughput Solexa Sequencing, supplied by Solexa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/small rnas (srnas) from the next generation high throughput solexa sequencing/product/Solexa
    Average 90 stars, based on 1 article reviews
    small rnas (srnas) from the next generation high throughput solexa sequencing - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk RNA-seq, and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.

    Journal: Cancer Informatics

    Article Title: Comparative RNA-Seq Analysis of Colon Spheroids and Patient-derived Tissues Identifies Non-Canonical Transcript Isoforms of Protein-Coding Genes Implicated in Colon Carcinogenesis

    doi: 10.1177/11769351251396250

    Figure Lengend Snippet: (A) Expression level of selected dysregulated transcripts NTMT1-204, BLOC1S6-218 and DCTN1-205 using patient data retrieved from UCSC Xena browser (n TCGA Tumor = 288, n TCGA Adjacent Non-Tumor Tissue = 41, n GTEx = 308). Data are presented as mean ± standard deviation (SD). **** P < .0001, n-number of samples. (B) Expression level of NTMT1-204 across colorectal cancer stages I-IV using patient data retrieved from UCSC Xena browser (n Stage I = 44, n Stage II = 109, n Stage III = 80, n Stage IV = 40). ** P < .01, n-number of samples. Data are derived from TCGA bulk RNA-seq, and observed expression patterns may be influenced by tumor purity and the presence of non-epithelial cell populations.

    Article Snippet: High-throughput next generation RNA sequencing was performed by Novogene (UK) Company Limited (Cambridge, United Kingdom).

    Techniques: Expressing, Standard Deviation, Derivative Assay, RNA Sequencing

    Summary characteristics of 16S rRNA sequence reads from fecal samples of rats fed 11% sugar solutions containing varying fructose-to-glucose ratios 1

    Journal: The Journal of Nutrition

    Article Title: Early-Life Sugar Consumption Affects the Rat Microbiome Independently of Obesity 1 2 3

    doi: 10.3945/jn.116.238816

    Figure Lengend Snippet: Summary characteristics of 16S rRNA sequence reads from fecal samples of rats fed 11% sugar solutions containing varying fructose-to-glucose ratios 1

    Article Snippet: Fecal microbiome populations were identified by using next-generation high-throughput sequencing of the V3–V4 variable region of 16S ribosomal RNA (rRNA; Vaiomer SAS).

    Techniques: Sequencing, Generated